Nexus Surgical and Medicare Ltd
BSE:538874

Watchlist Manager
Nexus Surgical and Medicare Ltd Logo
Nexus Surgical and Medicare Ltd
BSE:538874
Watchlist
Price: 17.55 INR -8.64% Market Closed
Market Cap: 96m INR
Section:
 

Relative Value

538874 price has not been updated for more than 3 years. This may indicate that the stock has been delisted.
538874 doesn't have a meaningful market cap.

The Relative Value of one NEXUSSURGL stock under the Base Case scenario is 23.72 INR. Compared to the current market price of 17.55 INR, Nexus Surgical and Medicare Ltd is Undervalued by 26%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NEXUSSURGL Relative Value
Base Case
23.72 INR
Undervaluation 26%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.7
P/S
P/S
Price to Sales
1.7
vs History
71
vs Industry
46
Median 3Y
2.3
Median 5Y
2.3
Industry
2.1
More Details
17.1
P/E
P/E
Price to Earnings
17.1
vs History
52
vs Industry
17
Median 3Y
22.9
Median 5Y
18
Industry
18.5
More Details
92.1
P/OCF
P/OCF
Price to OCF
92.1
vs History
11
vs Industry
6
Median 3Y
19.6
Median 5Y
25.6
Industry
11.2
More Details
98.9
P/FCFE
P/FCFE
Price to FCFE
98.9
vs History
11
vs Industry
12
Median 3Y
20
Median 5Y
20
Industry
14.3
More Details
9
P/B
P/B
Price to Book Value
9
vs History
77
vs Industry
7
Median 3Y
14.1
Median 5Y
16.7
Industry
1.8
More Details
1.6
EV/S
EV/S
Enterprise Value to Sales
1.6
vs History
73
vs Industry
49
Median 3Y
2.2
Median 5Y
2.2
Industry
3.2
More Details
2.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.4
vs History
49
vs Industry
58
Median 3Y
2.6
Median 5Y
2.5
Industry
6.9
More Details
12.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.3
vs History
52
vs Industry
14
Median 3Y
16.7
Median 5Y
13
Industry
11.1
More Details
12.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
12.4
vs History
52
vs Industry
15
Median 3Y
16.8
Median 5Y
13.1
Industry
13.4
More Details
88.5
EV/OCF
EV/OCF
Enterprise Value to OCF
88.5
vs History
11
vs Industry
8
Median 3Y
18.1
Median 5Y
22.4
Industry
11.3
More Details
95
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
95
vs History
11
vs Industry
8
Median 3Y
18.4
Median 5Y
22.4
Industry
12.1
More Details
12.8
EV/IC
EV/IC
Enterprise Value to IC
12.8
vs History
33
vs Industry
9
Median 3Y
11.4
Median 5Y
10.5
Industry
1.7
More Details

Multiples Across Competitors

NEXUSSURGL Competitors Multiples
Nexus Surgical and Medicare Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Nexus Surgical and Medicare Ltd
BSE:538874
96m INR 1.7 17.1 12.3 12.4
UK
Eight Capital Partners PLC
F:ECS
633.6T EUR 0 0 0 0
US
GE Vernova LLC
NYSE:GEV
168.9B USD 0 0 0 0
US
China Industrial Group Inc
OTC:CIND
121B USD 351.6 4 020.7 3 417.4 3 537.2
NL
Nepi Rockcastle NV
JSE:NRP
89.3B Zac 0 0 0 0
US
Reddit Inc
NYSE:RDDT
46.3B USD 24.3 132.6 158 167.6
CH
Galderma Group AG
SIX:GALD
39.2B CHF 0 0 0 0
US
Symbotic Inc
NASDAQ:SYM
42.1B USD 18.7 -2 482.8 -1 241.2 -563
US
Coupang Inc
F:788
35.2B EUR 1.2 104.9 27.9 45.9
US
CoreWeave Inc
NASDAQ:CRWV
39.2B USD 0 0 0 0
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
590.2T IDR 49.2 -135.9 2 858.6 2 858.6
P/S Multiple
Revenue Growth P/S to Growth
IN
Nexus Surgical and Medicare Ltd
BSE:538874
Average P/S: 74.5
1.7
N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
12%
N/A
US
C
China Industrial Group Inc
OTC:CIND
351.6
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-3%
N/A
US
R
Reddit Inc
NYSE:RDDT
24.3
44%
0.6
CH
G
Galderma Group AG
SIX:GALD
Not Available
18%
N/A
US
Symbotic Inc
NASDAQ:SYM
18.7
22%
0.9
US
Coupang Inc
F:788
1.2
16%
0.1
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
49.2
N/A N/A
P/E Multiple
Earnings Growth PEG
IN
Nexus Surgical and Medicare Ltd
BSE:538874
Average P/E: 1 068.9
17.1
N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
53%
N/A
US
C
China Industrial Group Inc
OTC:CIND
4 020.7
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-5%
N/A
US
R
Reddit Inc
NYSE:RDDT
132.6
N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
86%
N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -2 482.8 N/A N/A
US
Coupang Inc
F:788
104.9
118%
0.9
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
Negative Multiple: -135.9 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Nexus Surgical and Medicare Ltd
BSE:538874
Average EV/EBITDA: 1 294.9
12.3
N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
58%
N/A
US
C
China Industrial Group Inc
OTC:CIND
3 417.4
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-3%
N/A
US
R
Reddit Inc
NYSE:RDDT
158
N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
28%
N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -1 241.2 N/A N/A
US
Coupang Inc
F:788
27.9
56%
0.5
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
2 858.6
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
Nexus Surgical and Medicare Ltd
BSE:538874
Average EV/EBIT: 1 324.4
12.4
N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
99%
N/A
US
C
China Industrial Group Inc
OTC:CIND
3 537.2
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-4%
N/A
US
R
Reddit Inc
NYSE:RDDT
167.6
N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
39%
N/A
US
Symbotic Inc
NASDAQ:SYM
Negative Multiple: -563 N/A N/A
US
Coupang Inc
F:788
45.9
77%
0.6
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
2 858.6
N/A N/A

See Also

Summary
NEXUSSURGL intrinsic value, competitors valuation, and company profile.
DCF Valuation
NEXUSSURGL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NEXUSSURGL stock valuation using valuation multiples.
Wall Street Estimates
NEXUSSURGL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NEXUSSURGL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 308,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.